AU2011265205A1 - Nucleic acids for multiplex organism detection and methods of use and making the same - Google Patents
Nucleic acids for multiplex organism detection and methods of use and making the same Download PDFInfo
- Publication number
- AU2011265205A1 AU2011265205A1 AU2011265205A AU2011265205A AU2011265205A1 AU 2011265205 A1 AU2011265205 A1 AU 2011265205A1 AU 2011265205 A AU2011265205 A AU 2011265205A AU 2011265205 A AU2011265205 A AU 2011265205A AU 2011265205 A1 AU2011265205 A1 AU 2011265205A1
- Authority
- AU
- Australia
- Prior art keywords
- probe
- mixture
- sequence
- probes
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 156
- 150000007523 nucleic acids Chemical class 0.000 title claims description 86
- 102000039446 nucleic acids Human genes 0.000 title claims description 78
- 108020004707 nucleic acids Proteins 0.000 title claims description 78
- 238000001514 detection method Methods 0.000 title abstract description 30
- 239000000523 sample Substances 0.000 claims abstract description 926
- 239000000203 mixture Substances 0.000 claims abstract description 160
- 244000052769 pathogen Species 0.000 claims abstract description 52
- 125000003729 nucleotide group Chemical group 0.000 claims description 124
- 239000002773 nucleotide Substances 0.000 claims description 121
- 238000012163 sequencing technique Methods 0.000 claims description 101
- 241000282414 Homo sapiens Species 0.000 claims description 56
- 238000012360 testing method Methods 0.000 claims description 48
- 230000007717 exclusion Effects 0.000 claims description 38
- 238000009396 hybridization Methods 0.000 claims description 37
- 230000035772 mutation Effects 0.000 claims description 32
- 230000001717 pathogenic effect Effects 0.000 claims description 26
- 108091034117 Oligonucleotide Proteins 0.000 claims description 24
- 108091093088 Amplicon Proteins 0.000 claims description 15
- 241000894007 species Species 0.000 claims description 13
- 239000012472 biological sample Substances 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
- 241000700605 Viruses Species 0.000 claims description 10
- 230000001419 dependent effect Effects 0.000 claims description 10
- 241000206602 Eukaryota Species 0.000 claims description 9
- 238000003776 cleavage reaction Methods 0.000 claims description 9
- 230000007017 scission Effects 0.000 claims description 9
- 241000233866 Fungi Species 0.000 claims description 8
- 101710163270 Nuclease Proteins 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 241000124008 Mammalia Species 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 108091008146 restriction endonucleases Proteins 0.000 claims description 6
- 238000001574 biopsy Methods 0.000 claims description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 238000002493 microarray Methods 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 108010042407 Endonucleases Proteins 0.000 claims description 2
- 238000012217 deletion Methods 0.000 claims description 2
- 230000037430 deletion Effects 0.000 claims description 2
- 230000003252 repetitive effect Effects 0.000 claims description 2
- 238000007400 DNA extraction Methods 0.000 claims 1
- 102000004533 Endonucleases Human genes 0.000 claims 1
- 241000617156 archaeon Species 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 108700026220 vif Genes Proteins 0.000 claims 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 abstract description 10
- 239000002853 nucleic acid probe Substances 0.000 abstract description 10
- 230000003321 amplification Effects 0.000 description 70
- 238000003199 nucleic acid amplification method Methods 0.000 description 70
- 239000007795 chemical reaction product Substances 0.000 description 63
- 108020004414 DNA Proteins 0.000 description 59
- 238000006243 chemical reaction Methods 0.000 description 55
- 239000000047 product Substances 0.000 description 33
- 238000002844 melting Methods 0.000 description 31
- 230000008018 melting Effects 0.000 description 31
- 210000000349 chromosome Anatomy 0.000 description 25
- 238000003752 polymerase chain reaction Methods 0.000 description 24
- 230000000295 complement effect Effects 0.000 description 23
- 239000011159 matrix material Substances 0.000 description 23
- 238000004458 analytical method Methods 0.000 description 22
- 230000008569 process Effects 0.000 description 22
- 241000588724 Escherichia coli Species 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 18
- 208000019206 urinary tract infection Diseases 0.000 description 16
- 241000725303 Human immunodeficiency virus Species 0.000 description 15
- 241001138501 Salmonella enterica Species 0.000 description 15
- 102000053602 DNA Human genes 0.000 description 14
- 102000010029 Homer Scaffolding Proteins Human genes 0.000 description 14
- 108010077223 Homer Scaffolding Proteins Proteins 0.000 description 14
- 238000012545 processing Methods 0.000 description 13
- 241000588770 Proteus mirabilis Species 0.000 description 12
- 238000013461 design Methods 0.000 description 12
- 201000008827 tuberculosis Diseases 0.000 description 12
- 238000003556 assay Methods 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 108090000364 Ligases Proteins 0.000 description 10
- 102000003960 Ligases Human genes 0.000 description 10
- 241000193998 Streptococcus pneumoniae Species 0.000 description 10
- -1 swabs) Substances 0.000 description 10
- 230000003612 virological effect Effects 0.000 description 10
- 208000035657 Abasia Diseases 0.000 description 9
- 241000588747 Klebsiella pneumoniae Species 0.000 description 9
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 241000222122 Candida albicans Species 0.000 description 8
- 108060002716 Exonuclease Proteins 0.000 description 8
- 102000013165 exonuclease Human genes 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 150000002240 furans Chemical class 0.000 description 8
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 8
- 241001472782 Proteus penneri Species 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 229940095731 candida albicans Drugs 0.000 description 7
- 238000011049 filling Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 238000007481 next generation sequencing Methods 0.000 description 7
- 102000040430 polynucleotide Human genes 0.000 description 7
- 108091033319 polynucleotide Proteins 0.000 description 7
- 230000002441 reversible effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 108010063905 Ampligase Proteins 0.000 description 6
- 241000203069 Archaea Species 0.000 description 6
- 241000193163 Clostridioides difficile Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000003205 genotyping method Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000013610 patient sample Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
- 206010059866 Drug resistance Diseases 0.000 description 5
- 241000725643 Respiratory syncytial virus Species 0.000 description 5
- 101710084578 Short neurotoxin 1 Proteins 0.000 description 5
- 101710182532 Toxin a Proteins 0.000 description 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- 238000007480 sanger sequencing Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 108091032955 Bacterial small RNA Proteins 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 241000606768 Haemophilus influenzae Species 0.000 description 4
- 241000588748 Klebsiella Species 0.000 description 4
- 241001014264 Klebsiella variicola Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000588769 Proteus <enterobacteria> Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- 241000935255 Ureaplasma parvum Species 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000007418 data mining Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 241000589876 Campylobacter Species 0.000 description 3
- 201000007336 Cryptococcosis Diseases 0.000 description 3
- 241000221204 Cryptococcus neoformans Species 0.000 description 3
- 230000007067 DNA methylation Effects 0.000 description 3
- 241000709661 Enterovirus Species 0.000 description 3
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 3
- 102100029075 Exonuclease 1 Human genes 0.000 description 3
- 108091092584 GDNA Proteins 0.000 description 3
- 208000005176 Hepatitis C Diseases 0.000 description 3
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 3
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 3
- 201000009906 Meningitis Diseases 0.000 description 3
- 241000588653 Neisseria Species 0.000 description 3
- 241000202921 Ureaplasma urealyticum Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 208000002672 hepatitis B Diseases 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000011987 methylation Effects 0.000 description 3
- 238000007069 methylation reaction Methods 0.000 description 3
- 238000012175 pyrosequencing Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 239000002096 quantum dot Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000009781 safety test method Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 231100000041 toxicology testing Toxicity 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- 108020000946 Bacterial DNA Proteins 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 241001647372 Chlamydia pneumoniae Species 0.000 description 2
- 241000423301 Clostridioides difficile 630 Species 0.000 description 2
- 241000223205 Coccidioides immitis Species 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 241000223935 Cryptosporidium Species 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 241000588914 Enterobacter Species 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 241000194031 Enterococcus faecium Species 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101000876829 Homo sapiens Protein C-ets-1 Proteins 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 241000701027 Human herpesvirus 6 Species 0.000 description 2
- 241000829111 Human polyomavirus 1 Species 0.000 description 2
- 102000002698 KIR Receptors Human genes 0.000 description 2
- 108010043610 KIR Receptors Proteins 0.000 description 2
- 241000589242 Legionella pneumophila Species 0.000 description 2
- 241000186781 Listeria Species 0.000 description 2
- 241000186779 Listeria monocytogenes Species 0.000 description 2
- 108700011259 MicroRNAs Proteins 0.000 description 2
- 101150101095 Mmp12 gene Proteins 0.000 description 2
- 241000711386 Mumps virus Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
- 102100035251 Protein C-ets-1 Human genes 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 241000315672 SARS coronavirus Species 0.000 description 2
- 241000961587 Secoviridae Species 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 241000223109 Trypanosoma cruzi Species 0.000 description 2
- 241000101098 Xenotropic MuLV-related virus Species 0.000 description 2
- 241000607734 Yersinia <bacteria> Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000012938 design process Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
- 101150024289 hly gene Proteins 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000000126 in silico method Methods 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000011901 isothermal amplification Methods 0.000 description 2
- 229940115932 legionella pneumophila Drugs 0.000 description 2
- 235000019689 luncheon sausage Nutrition 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000007837 multiplex assay Methods 0.000 description 2
- 229940013390 mycoplasma pneumoniae Drugs 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 230000002186 photoactivation Effects 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012706 support-vector machine Methods 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 101150032575 tcdA gene Proteins 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- RLLPVAHGXHCWKJ-IEBWSBKVSA-N (3-phenoxyphenyl)methyl (1s,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-IEBWSBKVSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 108010037497 3'-nucleotidase Proteins 0.000 description 1
- JCLFHZLOKITRCE-UHFFFAOYSA-N 4-pentoxyphenol Chemical compound CCCCCOC1=CC=C(O)C=C1 JCLFHZLOKITRCE-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
- 241000701242 Adenoviridae Species 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241000606828 Aggregatibacter aphrophilus Species 0.000 description 1
- 241000175213 Alloherpesviridae Species 0.000 description 1
- 241000839461 Alphaendornavirus Species 0.000 description 1
- 241000961634 Alphaflexiviridae Species 0.000 description 1
- 241001135756 Alphaproteobacteria Species 0.000 description 1
- 241001339993 Anelloviridae Species 0.000 description 1
- 241000243790 Angiostrongylus cantonensis Species 0.000 description 1
- 241001156002 Anthonomus pomorum Species 0.000 description 1
- 241000224482 Apicomplexa Species 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 241000205054 Archaeoglobales Species 0.000 description 1
- 241000712892 Arenaviridae Species 0.000 description 1
- 241001292006 Arteriviridae Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000157873 Ascoviridae Species 0.000 description 1
- 241000977261 Asfarviridae Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241001533362 Astroviridae Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 102100021631 B-cell lymphoma 6 protein Human genes 0.000 description 1
- 108091012583 BCL2 Proteins 0.000 description 1
- 102000036365 BRCA1 Human genes 0.000 description 1
- 108700020463 BRCA1 Proteins 0.000 description 1
- 101150072950 BRCA1 gene Proteins 0.000 description 1
- 102000052609 BRCA2 Human genes 0.000 description 1
- 108700020462 BRCA2 Proteins 0.000 description 1
- 241000223836 Babesia Species 0.000 description 1
- 241000193833 Bacillales Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000605059 Bacteroidetes Species 0.000 description 1
- 241000701412 Baculoviridae Species 0.000 description 1
- 241001533460 Barnaviridae Species 0.000 description 1
- 241001279892 Benyvirus Species 0.000 description 1
- 241001135755 Betaproteobacteria Species 0.000 description 1
- 241001340646 Bicaudaviridae Species 0.000 description 1
- 241000702628 Birnaviridae Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000228405 Blastomyces dermatitidis Species 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000776207 Bornaviridae Species 0.000 description 1
- 241000589969 Borreliella burgdorferi Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101150008921 Brca2 gene Proteins 0.000 description 1
- 241001533462 Bromoviridae Species 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- 102100025074 C-C chemokine receptor-like 2 Human genes 0.000 description 1
- 241000714198 Caliciviridae Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000520666 Carmotetraviridae Species 0.000 description 1
- 241001137855 Caudovirales Species 0.000 description 1
- 241001115395 Caulimoviridae Species 0.000 description 1
- 241001218361 Cheravirus Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241001185363 Chlamydiae Species 0.000 description 1
- 241000191368 Chlorobi Species 0.000 description 1
- 241001060419 Chrysoviridae Species 0.000 description 1
- 241001533399 Circoviridae Species 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 241000588917 Citrobacter koseri Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000973027 Closteroviridae Species 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 241001522796 Clostridioides difficile CD196 Species 0.000 description 1
- 241001522791 Clostridioides difficile R20291 Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 108010065152 Coagulase Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 241000701520 Corticoviridae Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 108091029523 CpG island Proteins 0.000 description 1
- 241001137853 Crenarchaeota Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 108010076010 Cystathionine beta-lyase Proteins 0.000 description 1
- 241000702221 Cystoviridae Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical group OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 108050009160 DNA polymerase 1 Proteins 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- 241001135761 Deltaproteobacteria Species 0.000 description 1
- 241001533413 Deltavirus Species 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 241000188738 Desulfurococcales Species 0.000 description 1
- 241000615461 Dicistroviridae Species 0.000 description 1
- 241000224460 Diplomonadida Species 0.000 description 1
- 102100035813 E3 ubiquitin-protein ligase CBL Human genes 0.000 description 1
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 1
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241001148568 Epsilonproteobacteria Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 1
- 101710196289 Eukaryotic translation initiation factor 2-alpha kinase 1 Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 102100037091 Exonuclease V Human genes 0.000 description 1
- 108050006542 Exonuclease V Proteins 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000711950 Filoviridae Species 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 241000723722 Furovirus Species 0.000 description 1
- 241000701367 Fuselloviridae Species 0.000 description 1
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 1
- 102100029974 GTPase HRas Human genes 0.000 description 1
- 102100039788 GTPase NRas Human genes 0.000 description 1
- 241000192128 Gammaproteobacteria Species 0.000 description 1
- 241000702463 Geminiviridae Species 0.000 description 1
- 241000224466 Giardia Species 0.000 description 1
- 241000224467 Giardia intestinalis Species 0.000 description 1
- 241001136687 Globuloviridae Species 0.000 description 1
- 241001276383 Gnathostoma spinigerum Species 0.000 description 1
- 241000205038 Halobacteriales Species 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 241000700739 Hepadnaviridae Species 0.000 description 1
- 241001122120 Hepeviridae Species 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- 241000700586 Herpesviridae Species 0.000 description 1
- 101710121996 Hexon protein p72 Proteins 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 1
- 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 description 1
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 1
- 101000980756 Homo sapiens G1/S-specific cyclin-D1 Proteins 0.000 description 1
- 101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 1
- 101000744505 Homo sapiens GTPase NRas Proteins 0.000 description 1
- 101001064870 Homo sapiens Lon protease homolog, mitochondrial Proteins 0.000 description 1
- 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 1
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 description 1
- 101000585703 Homo sapiens Protein L-Myc Proteins 0.000 description 1
- 101000573199 Homo sapiens Protein PML Proteins 0.000 description 1
- 101000861454 Homo sapiens Protein c-Fos Proteins 0.000 description 1
- 101000579425 Homo sapiens Proto-oncogene tyrosine-protein kinase receptor Ret Proteins 0.000 description 1
- 101000857677 Homo sapiens Runt-related transcription factor 1 Proteins 0.000 description 1
- 101000595531 Homo sapiens Serine/threonine-protein kinase pim-1 Proteins 0.000 description 1
- 101000891113 Homo sapiens T-cell acute lymphocytic leukemia protein 1 Proteins 0.000 description 1
- 101000800488 Homo sapiens T-cell leukemia homeobox protein 1 Proteins 0.000 description 1
- 101000837626 Homo sapiens Thyroid hormone receptor alpha Proteins 0.000 description 1
- 101000813738 Homo sapiens Transcription factor ETV6 Proteins 0.000 description 1
- 101000636213 Homo sapiens Transcriptional activator Myb Proteins 0.000 description 1
- 101000823316 Homo sapiens Tyrosine-protein kinase ABL1 Proteins 0.000 description 1
- 101000912503 Homo sapiens Tyrosine-protein kinase Fgr Proteins 0.000 description 1
- 101001022129 Homo sapiens Tyrosine-protein kinase Fyn Proteins 0.000 description 1
- 241000724309 Hordeivirus Species 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- 241001533448 Hypoviridae Species 0.000 description 1
- 101150005343 INHA gene Proteins 0.000 description 1
- 241001533403 Idaeovirus Species 0.000 description 1
- 241000615454 Iflavirus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000702394 Inoviridae Species 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 241000701377 Iridoviridae Species 0.000 description 1
- 241000701460 JC polyomavirus Species 0.000 description 1
- 241000222712 Kinetoplastida Species 0.000 description 1
- 206010061259 Klebsiella infection Diseases 0.000 description 1
- 208000024233 Klebsiella infectious disease Diseases 0.000 description 1
- 241001112724 Lactobacillales Species 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 101710128836 Large T antigen Proteins 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 241000714210 Leviviridae Species 0.000 description 1
- 241000701365 Lipothrixviridae Species 0.000 description 1
- 241000253097 Luteoviridae Species 0.000 description 1
- 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 1
- 108700012912 MYCN Proteins 0.000 description 1
- 101150022024 MYCN gene Proteins 0.000 description 1
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 241000175209 Malacoherpesviridae Species 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 241001661687 Marnaviridae Species 0.000 description 1
- 238000007476 Maximum Likelihood Methods 0.000 description 1
- 241000203067 Methanobacteriales Species 0.000 description 1
- 241000203361 Methanococcales Species 0.000 description 1
- 241000959683 Methanopyrales Species 0.000 description 1
- 101000829705 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) Thermosome subunit Proteins 0.000 description 1
- 241000359380 Methanosarcinales Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 241000243190 Microsporidia Species 0.000 description 1
- 241000702318 Microviridae Species 0.000 description 1
- 241000186187 Mimiviridae Species 0.000 description 1
- 241000711513 Mononegavirales Species 0.000 description 1
- 241000588621 Moraxella Species 0.000 description 1
- 241000588655 Moraxella catarrhalis Species 0.000 description 1
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 1
- 101100107522 Mus musculus Slc1a5 gene Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 241000545499 Mycobacterium avium-intracellulare Species 0.000 description 1
- 241001646722 Mycobacterium tuberculosis CDC1551 Species 0.000 description 1
- 241000385073 Mycobacterium tuberculosis F11 Species 0.000 description 1
- 241001049988 Mycobacterium tuberculosis H37Ra Species 0.000 description 1
- 241001646725 Mycobacterium tuberculosis H37Rv Species 0.000 description 1
- 108700035964 Mycobacterium tuberculosis HsaD Proteins 0.000 description 1
- 241001580620 Mycobacterium tuberculosis KZN 1435 Species 0.000 description 1
- 241000701553 Myoviridae Species 0.000 description 1
- 108700026495 N-Myc Proto-Oncogene Proteins 0.000 description 1
- 102100030124 N-myc proto-oncogene protein Human genes 0.000 description 1
- 241000224438 Naegleria fowleri Species 0.000 description 1
- 241001437658 Nanoarchaeota Species 0.000 description 1
- 241001336717 Nanoviridae Species 0.000 description 1
- 241001112477 Narnaviridae Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 241001292005 Nidovirales Species 0.000 description 1
- 241001484257 Nimaviridae Species 0.000 description 1
- 241000723741 Nodaviridae Species 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 241000015083 Ophiovirus Species 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 241001112506 Ourmiavirus Species 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 241000711504 Paramyxoviridae Species 0.000 description 1
- 241000710936 Partitiviridae Species 0.000 description 1
- 241000701945 Parvoviridae Species 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000264850 Pecluvirus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 241000150350 Peribunyaviridae Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241001326562 Pezizomycotina Species 0.000 description 1
- 241000701253 Phycodnaviridae Species 0.000 description 1
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 1
- 241001144416 Picornavirales Species 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 241000701369 Plasmaviridae Species 0.000 description 1
- 241000702072 Podoviridae Species 0.000 description 1
- 241000701374 Polydnaviridae Species 0.000 description 1
- 241001631648 Polyomaviridae Species 0.000 description 1
- 241001112830 Pomovirus Species 0.000 description 1
- 241001533393 Potyviridae Species 0.000 description 1
- 241000700625 Poxviridae Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 102100030128 Protein L-Myc Human genes 0.000 description 1
- 102100026375 Protein PML Human genes 0.000 description 1
- 102100027584 Protein c-Fos Human genes 0.000 description 1
- 208000022274 Proteus Infections Diseases 0.000 description 1
- 208000011501 Proteus infectious disease Diseases 0.000 description 1
- 102100028286 Proto-oncogene tyrosine-protein kinase receptor Ret Human genes 0.000 description 1
- 241000576783 Providencia alcalifaciens Species 0.000 description 1
- 241000588777 Providencia rettgeri Species 0.000 description 1
- 241000043392 Providencia rustigianii Species 0.000 description 1
- 241000205156 Pyrococcus furiosus Species 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 241000702247 Reoviridae Species 0.000 description 1
- 241000712907 Retroviridae Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000711931 Rhabdoviridae Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000606651 Rickettsiales Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241001534527 Roniviridae Species 0.000 description 1
- 241000040592 Rudiviridae Species 0.000 description 1
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 description 1
- 101150019443 SMAD4 gene Proteins 0.000 description 1
- 102000001332 SRC Human genes 0.000 description 1
- 108060006706 SRC Proteins 0.000 description 1
- 241001326564 Saccharomycotina Species 0.000 description 1
- 241001596272 Sadwavirus Species 0.000 description 1
- 241000607356 Salmonella enterica subsp. arizonae Species 0.000 description 1
- 241000789939 Salmonella enterica subsp. enterica serovar Agona str. SL483 Species 0.000 description 1
- 241001617476 Salmonella enterica subsp. enterica serovar Choleraesuis str. SC-B67 Species 0.000 description 1
- 241000125693 Salmonella enterica subsp. enterica serovar Dublin str. CT_02021853 Species 0.000 description 1
- 241000458510 Salmonella enterica subsp. enterica serovar Enteritidis str. P125109 Species 0.000 description 1
- 241000458513 Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 Species 0.000 description 1
- 241000789937 Salmonella enterica subsp. enterica serovar Heidelberg str. SL476 Species 0.000 description 1
- 241001340628 Salmonella enterica subsp. enterica serovar Newport str. SL254 Species 0.000 description 1
- 241000494511 Salmonella enterica subsp. enterica serovar Paratyphi A str. AKU_12601 Species 0.000 description 1
- 241001175683 Salmonella enterica subsp. enterica serovar Paratyphi A str. ATCC 9150 Species 0.000 description 1
- 241000242340 Salmonella enterica subsp. enterica serovar Paratyphi B str. SPB7 Species 0.000 description 1
- 241001551912 Salmonella enterica subsp. enterica serovar Paratyphi C str. RKS4594 Species 0.000 description 1
- 241000125686 Salmonella enterica subsp. enterica serovar Schwarzengrund str. CVM19633 Species 0.000 description 1
- 241000225553 Salmonella enterica subsp. enterica serovar Typhi str. CT18 Species 0.000 description 1
- 241001248470 Salmonella enterica subsp. enterica serovar Typhi str. Ty2 Species 0.000 description 1
- 241001053778 Salterprovirus Species 0.000 description 1
- 101000702553 Schistosoma mansoni Antigen Sm21.7 Proteins 0.000 description 1
- 101000714192 Schistosoma mansoni Tegument antigen Proteins 0.000 description 1
- 241001326539 Schizosaccharomycetes Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 102100036077 Serine/threonine-protein kinase pim-1 Human genes 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 241000702202 Siphoviridae Species 0.000 description 1
- 108700031298 Smad4 Proteins 0.000 description 1
- 241000710119 Sobemovirus Species 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241001466451 Stramenopiles Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000273172 Streptococcus pneumoniae 70585 Species 0.000 description 1
- 241000823701 Streptococcus pneumoniae ATCC 700669 Species 0.000 description 1
- 241000727755 Streptococcus pneumoniae CGSP14 Species 0.000 description 1
- 241000130810 Streptococcus pneumoniae D39 Species 0.000 description 1
- 241000674319 Streptococcus pneumoniae G54 Species 0.000 description 1
- 241000273161 Streptococcus pneumoniae JJA Species 0.000 description 1
- 241000273164 Streptococcus pneumoniae P1031 Species 0.000 description 1
- 241000694196 Streptococcus pneumoniae R6 Species 0.000 description 1
- 241000683224 Streptococcus pneumoniae TIGR4 Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000205074 Sulfolobales Species 0.000 description 1
- 102100040365 T-cell acute lymphocytic leukemia protein 1 Human genes 0.000 description 1
- 102100033111 T-cell leukemia homeobox protein 1 Human genes 0.000 description 1
- 241000701521 Tectiviridae Species 0.000 description 1
- 241000724318 Tenuivirus Species 0.000 description 1
- 241000204969 Thermococcales Species 0.000 description 1
- 241000204668 Thermoplasmatales Species 0.000 description 1
- 241000205177 Thermoproteales Species 0.000 description 1
- 102100028702 Thyroid hormone receptor alpha Human genes 0.000 description 1
- 241000723848 Tobamovirus Species 0.000 description 1
- 241000723717 Tobravirus Species 0.000 description 1
- 241000710924 Togaviridae Species 0.000 description 1
- 241001533336 Tombusviridae Species 0.000 description 1
- 241000710915 Totiviridae Species 0.000 description 1
- 102100039580 Transcription factor ETV6 Human genes 0.000 description 1
- 102100030780 Transcriptional activator Myb Human genes 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 241001059845 Tymoviridae Species 0.000 description 1
- 102100022596 Tyrosine-protein kinase ABL1 Human genes 0.000 description 1
- 102100026150 Tyrosine-protein kinase Fgr Human genes 0.000 description 1
- 102100035221 Tyrosine-protein kinase Fyn Human genes 0.000 description 1
- 241001533358 Umbravirus Species 0.000 description 1
- 241000202898 Ureaplasma Species 0.000 description 1
- 206010046367 Ureaplasma infections Diseases 0.000 description 1
- 208000025833 Ureaplasma urethritis Diseases 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 208000028227 Viral hemorrhagic fever Diseases 0.000 description 1
- 241000710886 West Nile virus Species 0.000 description 1
- 241000520892 Xanthomonas axonopodis Species 0.000 description 1
- 241000204362 Xylella fastidiosa Species 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
- 241000758405 Zoopagomycotina Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 108700010877 adenoviridae proteins Proteins 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 101150090348 atpC gene Proteins 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 238000013476 bayesian approach Methods 0.000 description 1
- 101150035306 bexA gene Proteins 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000001369 bisulfite sequencing Methods 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000013625 clathrin-independent carrier Substances 0.000 description 1
- 201000003486 coccidioidomycosis Diseases 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000013527 convolutional neural network Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 101150059761 ctrA gene Proteins 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- SPTYHKZRPFATHJ-HYZXJONISA-N dT6 Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)CO)[C@@H](O)C1 SPTYHKZRPFATHJ-HYZXJONISA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 101150015947 fimH gene Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 101150036031 gD gene Proteins 0.000 description 1
- 101150020597 gG gene Proteins 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 244000037671 genetically modified crops Species 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 101150013736 gyrB gene Proteins 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 229940045808 haemophilus influenzae type b Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003499 nucleic acid array Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 description 1
- 229960003752 oseltamivir Drugs 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 101150073755 papX gene Proteins 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 101150063938 ply gene Proteins 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 229940049413 rifampicin and isoniazid Drugs 0.000 description 1
- 101150090202 rpoB gene Proteins 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940115939 shigella sonnei Drugs 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35401110P | 2010-06-11 | 2010-06-11 | |
| US61/354,011 | 2010-06-11 | ||
| US37404110P | 2010-08-16 | 2010-08-16 | |
| US61/374,041 | 2010-08-16 | ||
| US201161439167P | 2011-02-03 | 2011-02-03 | |
| US61/439,167 | 2011-02-03 | ||
| PCT/US2011/040106 WO2011156795A2 (en) | 2010-06-11 | 2011-06-10 | Nucleic acids for multiplex organism detection and methods of use and making the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2011265205A1 true AU2011265205A1 (en) | 2013-01-31 |
Family
ID=45098726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011265205A Abandoned AU2011265205A1 (en) | 2010-06-11 | 2011-06-10 | Nucleic acids for multiplex organism detection and methods of use and making the same |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20130261196A1 (enExample) |
| EP (1) | EP2580354A4 (enExample) |
| JP (1) | JP2013531983A (enExample) |
| AU (1) | AU2011265205A1 (enExample) |
| SG (1) | SG186987A1 (enExample) |
| WO (1) | WO2011156795A2 (enExample) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| WO2010009365A1 (en) | 2008-07-18 | 2010-01-21 | Raindance Technologies, Inc. | Droplet libraries |
| EP4484577A3 (en) | 2010-02-12 | 2025-03-26 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US10351905B2 (en) * | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
| WO2013173795A1 (en) * | 2012-05-18 | 2013-11-21 | Pathogenica, Inc. | Realtime sequence based biosurveillance system |
| WO2013173774A2 (en) * | 2012-05-18 | 2013-11-21 | Pathogenica, Inc. | Molecular inversion probes |
| EP2946345B1 (en) | 2013-01-17 | 2024-04-03 | Personalis, Inc. | Methods and systems for genetic analysis |
| ES2900102T3 (es) * | 2013-02-20 | 2022-03-15 | Univ Emory | Composiciones para la secuenciación de ácidos nucleicos en mezclas |
| AU2013382195B2 (en) | 2013-03-13 | 2019-09-19 | Illumina, Inc. | Methods and systems for aligning repetitive DNA elements |
| CN105358709B (zh) * | 2013-03-15 | 2018-12-07 | 雅培分子公司 | 用于检测基因组拷贝数变化的系统和方法 |
| US20150141257A1 (en) * | 2013-08-02 | 2015-05-21 | Roche Nimblegen, Inc. | Sequence capture method using specialized capture probes (heatseq) |
| WO2015031385A1 (en) | 2013-08-26 | 2015-03-05 | The Translational Genomics Research Institute | Single molecule-overlapping read analysis for minor variant mutation detection in pathogen samples |
| EP4567682A3 (en) | 2013-08-30 | 2025-09-03 | Personalis, Inc. | Methods for genomic analysis |
| WO2015071552A1 (en) * | 2013-11-18 | 2015-05-21 | Teknologian Tutkimuskeskus Vtt | Multi-unit probes with high specificity and a method of designing the same |
| WO2015157696A1 (en) * | 2014-04-11 | 2015-10-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for metagenome biomarker detection |
| JP6976167B2 (ja) | 2014-06-13 | 2021-12-08 | キュー−リネア エービー | 微生物の検出及び特徴付け方法 |
| EP2960818A1 (en) * | 2014-06-24 | 2015-12-30 | Institut Pasteur | Method, device, and computer program for assembling pieces of chromosomes from one or several organisms |
| EP4026913A1 (en) | 2014-10-30 | 2022-07-13 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
| TWI577803B (zh) * | 2015-01-15 | 2017-04-11 | 昕穎生醫技術股份有限公司 | 多重抗藥性結核病篩檢方法及套組 |
| GB201507026D0 (en) | 2015-04-24 | 2015-06-10 | Linea Ab Q | Medical sample transportation container |
| KR20180071299A (ko) * | 2015-10-18 | 2018-06-27 | 아피메트릭스, 인코포레이티드 | 단일 뉴클레오타이드 다형 및 인델의 다대립유전자 유전자형분석 |
| CN116987777A (zh) * | 2016-03-25 | 2023-11-03 | 凯锐思公司 | 合成核酸掺入物 |
| GB2554767A (en) | 2016-04-21 | 2018-04-11 | Q Linea Ab | Detecting and characterising a microorganism |
| US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
| US10337051B2 (en) | 2016-06-16 | 2019-07-02 | The Regents Of The University Of California | Methods and compositions for detecting a target RNA |
| JP7306696B2 (ja) | 2016-09-30 | 2023-07-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Ｒｎａ誘導型核酸修飾酵素及びその使用方法 |
| CN110023494A (zh) | 2016-09-30 | 2019-07-16 | 加利福尼亚大学董事会 | Rna指导的核酸修饰酶及其使用方法 |
| US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| EP3630790B1 (en) * | 2017-05-23 | 2023-05-10 | Rutgers, The State University of New Jersey | Target mediatedin situ |
| CA3071855C (en) | 2017-08-04 | 2021-09-14 | Billiontoone, Inc. | Target-associated molecules for characterization associated with biological targets |
| ES2923478T3 (es) | 2017-08-04 | 2022-09-27 | Billiontoone Inc | Determinación y análisis de resultados de una secuenciación con moléculas asociadas a una diana en una cuantificación asociada con dianas biológicas |
| US11519024B2 (en) | 2017-08-04 | 2022-12-06 | Billiontoone, Inc. | Homologous genomic regions for characterization associated with biological targets |
| WO2019089808A1 (en) | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Class 2 crispr/cas compositions and methods of use |
| WO2019089804A1 (en) | 2017-11-01 | 2019-05-09 | The Regents Of The University Of California | Casy compositions and methods of use |
| BR112020008654A2 (pt) | 2017-11-01 | 2020-11-10 | The Regents Of The University Of California | composições casz e métodos de uso |
| EP4335928B1 (en) | 2018-01-05 | 2025-10-29 | BillionToOne, Inc. | Quality control templates for ensuring validity of sequencing-based assays |
| SG11202007686VA (en) | 2018-02-12 | 2020-09-29 | 10X Genomics Inc | Methods characterizing multiple analytes from individual cells or cell populations |
| US11639928B2 (en) | 2018-02-22 | 2023-05-02 | 10X Genomics, Inc. | Methods and systems for characterizing analytes from individual cells or cell populations |
| WO2019169028A1 (en) | 2018-02-28 | 2019-09-06 | 10X Genomics, Inc. | Transcriptome sequencing through random ligation |
| US11702653B2 (en) | 2018-05-21 | 2023-07-18 | Battelle Memorial Institute | Control compositions and methods for sequencing |
| US10801064B2 (en) * | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| EP3830301B1 (en) | 2018-08-01 | 2024-05-22 | Mammoth Biosciences, Inc. | Programmable nuclease compositions and methods of use thereof |
| WO2020033425A1 (en) | 2018-08-06 | 2020-02-13 | Billiontoone, Inc. | Dilution tagging for quantification of biological targets |
| CA3118990A1 (en) | 2018-11-21 | 2020-05-28 | Karius, Inc. | Direct-to-library methods, systems, and compositions |
| WO2020124003A1 (en) | 2018-12-13 | 2020-06-18 | Battelle Memorial Institute | Methods and control compositions for a quantitative polymerase chain reaction |
| WO2020142754A2 (en) | 2019-01-04 | 2020-07-09 | Mammoth Biosciences, Inc. | Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection |
| US11920183B2 (en) | 2019-03-11 | 2024-03-05 | 10X Genomics, Inc. | Systems and methods for processing optically tagged beads |
| CN111508561B (zh) * | 2019-07-04 | 2024-02-06 | 北京希望组生物科技有限公司 | 同源序列和同源序列中串联重复序列的检测方法、计算机可读介质和应用 |
| CN110592208B (zh) * | 2019-10-08 | 2022-05-03 | 北京诺禾致源科技股份有限公司 | 地中海贫血症三类亚型的捕获探针组合物及其应用方法和应用装置 |
| WO2022182682A1 (en) | 2021-02-23 | 2022-09-01 | 10X Genomics, Inc. | Probe-based analysis of nucleic acids and proteins |
| EP4108783B1 (en) * | 2021-06-24 | 2024-02-21 | Miltenyi Biotec B.V. & Co. KG | Spatial sequencing with mictag |
| EP4413580A4 (en) | 2021-10-05 | 2025-08-13 | Personalis Inc | PERSONALIZED TESTS FOR PERSONALIZED CANCER MONITORING |
| AU2023240345A1 (en) | 2022-03-21 | 2024-10-10 | Billion Toone, Inc. | Molecule counting of methylated cell-free dna for treatment monitoring |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030134293A1 (en) * | 1999-11-16 | 2003-07-17 | Zhiping Liu | Method for rapid and accurate identification of microorganisms |
| US6858412B2 (en) * | 2000-10-24 | 2005-02-22 | The Board Of Trustees Of The Leland Stanford Junior University | Direct multiplex characterization of genomic DNA |
| EP1522853A4 (en) * | 2002-06-24 | 2005-10-19 | Canon Kk | DNA MICROARRAY WITH STANDARD PROBE AND KIT CONTAINING THE MICROARRAY |
| WO2005113804A1 (en) * | 2004-05-20 | 2005-12-01 | Trillion Genomics Limited | Use of mass labelled probes to detect target nucleic acids using mass spectrometry |
| WO2007106407A2 (en) * | 2006-03-10 | 2007-09-20 | Wyeth | Microarray for monitoring gene expression in multiple strains of streptococcus pneumoniae |
| US7897747B2 (en) * | 2006-05-25 | 2011-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Method to produce single stranded DNA of defined length and sequence and DNA probes produced thereby |
| BRPI1012951A2 (pt) * | 2009-06-09 | 2016-07-26 | Defyrus Inc | "administração de interferon para profilaxia ou tratamento de infecção por patôgeno" |
-
2011
- 2011-06-10 US US13/703,489 patent/US20130261196A1/en not_active Abandoned
- 2011-06-10 EP EP11793299.6A patent/EP2580354A4/en not_active Withdrawn
- 2011-06-10 AU AU2011265205A patent/AU2011265205A1/en not_active Abandoned
- 2011-06-10 SG SG2013001573A patent/SG186987A1/en unknown
- 2011-06-10 JP JP2013514408A patent/JP2013531983A/ja active Pending
- 2011-06-10 WO PCT/US2011/040106 patent/WO2011156795A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2580354A4 (en) | 2013-10-30 |
| WO2011156795A3 (en) | 2012-04-05 |
| JP2013531983A (ja) | 2013-08-15 |
| WO2011156795A2 (en) | 2011-12-15 |
| US20130261196A1 (en) | 2013-10-03 |
| SG186987A1 (en) | 2013-02-28 |
| EP2580354A2 (en) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20130261196A1 (en) | Nucleic Acids For Multiplex Organism Detection and Methods Of Use And Making The Same | |
| EP4443436A2 (en) | Universal short adapters for indexing of polynucleotide | |
| Novais et al. | The evolution of Pyrosequencing® for microbiology: from genes to genomes | |
| AU2018331434A1 (en) | Universal short adapters with variable length non-random unique molecular identifiers | |
| US20150344973A1 (en) | Method and System for Detection of an Organism | |
| WO2013173774A2 (en) | Molecular inversion probes | |
| EP4041918B1 (en) | Methods and systems for assessing microbial populations | |
| WO2013067167A2 (en) | Method and system for detection of an organism | |
| US20160115544A1 (en) | Molecular barcoding for multiplex sequencing | |
| BRPI0517131B1 (pt) | Métodos para simplificar ácidos nucléicos microbiais por modificação química de citosinas | |
| US20220267833A1 (en) | Detection of genomic sequences using combinations of probes, probe molecules and arrays comprising the probes for the specific detection of organisms | |
| CN116964187A (zh) | 扩增子甲基化序列分析用引物的设计方法、制造方法、设计装置、设计程序及记录介质 | |
| JP2023520590A (ja) | 病原体診断検査 | |
| WO2013173795A1 (en) | Realtime sequence based biosurveillance system | |
| WO2013040060A2 (en) | Nucleic acids for multiplex detection of hepatitis c virus | |
| US20210017582A1 (en) | Detection of genomic sequences and probe molecules therefor | |
| Park et al. | Detection strategies for foodborne salmonella and prospects for utilization of whole genome sequencing approaches | |
| Bajaj et al. | MICROBIAL GENOMICS | |
| US20240203528A1 (en) | Improved detection of genomic sequences and probe molecules therefor | |
| WO2024030342A1 (en) | Methods and compositions for nucleic acid analysis | |
| TW202246525A (zh) | 基因體序列之改善之偵測及用於其之探針分子 | |
| CN114277183A (zh) | 一种5种人肠病毒的mnp标记组合、引物对组合、试剂盒及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |